Class IITerminatedVoluntary: Firm initiated
Extract Labs, Inc.: food recall H-0622-2025
Extract Labs, Inc. of Lafayette, CO recalled Elderberry 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement… Reason: Potential peanut protein cross-contact. The FDA listed it as Class II in its Enforcement Report dated Oct 1, 2025; distribution: nationwide.
Record status as published: Terminated (terminated Oct 30, 2025). openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Elderberry 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Elderberry: 24 bags x 5kg and 1 bag x 3.6kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label)
- Product quantity
- 19,720 gummies
- Reason for recall
- Potential peanut protein cross-contact.
- Codes, lots and dates on the package
- Lot: 25JD072107A EXP: 07/2027 Printed on bulk bag identifier adhesive
- Distribution pattern
- Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand.
- Recalling firm
- Extract Labs, Inc., Lafayette, CO
- Classification
- Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Aug 26, 2025 |
| Classified by the FDA | Sep 22, 2025 |
| Published in the Enforcement Report | Oct 1, 2025 |
| Terminated | Oct 30, 2025 |
Other products in the same recall event
The FDA groups related products under one recall event (event 97500).
- H-0624-2025 — Mai Tai 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines…
- H-0623-2025 — Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines…
- H-0621-2025 — Sugar-free Mixed Berry Gummies Brand Name: Extract Labs Generic Name: Dietary Supplement Strength: 10mg CBD and 10mg D9 THC per gummy Dosage: 1 gummy Form: Gummy Administration: Oral Intended use: Dietary Supplement…
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0622-2025 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.